Steven L. Hoerter, President and CEO: Deciphera Pharmaceuticals DCPH Sell · Filed 23/10/31

Trade details

Type: Insider sale
Amount: $259,307.46
Shares · price: 21,573 sh · $12.02 a share
Held after: 40,927 sh
Stock: Deciphera Pharmaceuticals DCPH
Person: Steven L. HoerterPresident and CEO
Trade date: 23/10/30
Filed: 23/10/31
Days to filing: 1 days

Sold 34.5% of holdings

Share of holding sold: 34.5%

Deciphera Pharmaceuticals trades, last 26 weeks

What else happened in Deciphera Pharmaceuticals around then

Filed or reported within 30 days of the trade day · 23/09/30~23/11/29

Steven L. Hoerter's recent trades

Steven L. HoerterDirector
BuyMBX Biosciences
Buy
MBX Biosciences
MBX
$265K
20,000 sh
$265K
Filed 25/10/20
Traded 25/10/17
Steven L. HoerterPresident and CEO
SellDeciphera Pharmaceuticals
Sell
Deciphera Pharmaceuticals
DCPH
$471.3K
30,664 sh
$471.3K
Filed 23/12/14
Traded 23/12/13
Steven L. HoerterPresident and CEO
SellDeciphera Pharmaceuticals
Sell
Deciphera Pharmaceuticals
DCPH
$116.8K
7,500 sh
$116.8K
Filed 23/03/23
Traded 23/03/21
Steven L. HoerterPresident and CEO
SellDeciphera Pharmaceuticals
Sell
Deciphera Pharmaceuticals
DCPH
$480.7K
30,045 sh
$480.7K
Filed 23/02/16
Traded 23/02/14